Jul 29, 2021 / 05:00PM GMT
Operator
Good day, and thank you for standing by. Welcome to the conference call being hosted today by Alector's management. (Operator Instructions)
Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Ms. Michelle Coral. You may begin.
Michelle Corral - Alector, Inc. - VP of Communications & IR
Thank you, Kara. Good morning, and thank you all for joining us on today's call. I'm Michelle Corral, Alector's Vice President of Communications and Investor Relations. Today, we will be reviewing results from the INFRONT-2 Phase II clinical trial. These data were presented earlier today at the Alzheimer's Association International Conference, and that presentation is posted to the Investors section of the Alector website under Events and Presentations.
A press release detailing the data was also issued this morning and can be found on our website as well.
On today's call, we have CEO and Co-Founder, Dr. Arnon Rosenthal; Dr. Shehnaaz
Alector Inc to Review the AL001 Phase 2 Results- Conference Call Transcript
Jul 29, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers